<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zangari J</submitter><funding>Oncosuisse</funding><funding>Swiss National Science Foundation</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Deutsche Forschungsgemeinschaft (German Research Foundation)</funding><funding>Fondation Ernst et Lucie Schmidheiny</funding><funding>Oncosuisse (OCS)</funding><pagination>1646-1662</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12373508</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(8)</volume><pubmed_abstract>Selective targeting of cancer cells is a major challenge for cancer therapy. Many cancer cells overexpress the cystine/glutamate antiporter xCT/CD98, an L-cystine transport system that strengthens antioxidant defences, thereby promoting tumour survival and progression. Here, we show that the D-enantiomer of cysteine (D-Cys) is selectively imported into xCT/CD98-overexpressing cancer cell lines and impairs their proliferation, particularly under high oxygen concentrations. Intracellular D-Cys specifically inhibits the mitochondrial cysteine desulfurase NFS1, a key enzyme of cellular iron-sulfur protein biogenesis, by blocking sulfur mobilization due to steric constraints. NFS1 inhibition by D-Cys affects all cellular iron-sulfur cluster-dependent functions, including mitochondrial respirati</pubmed_abstract><journal>Nature metabolism</journal><pubmed_title>D-cysteine impairs tumour growth by inhibiting cysteine desulfurase NFS1.</pubmed_title><pmcid>PMC12373508</pmcid><funding_grant_id>KFS-4434-02-2018</funding_grant_id><funding_grant_id>Koselleck grant LI 415/6 and SPP 1927; LI 415/7</funding_grant_id><funding_grant_id>179421</funding_grant_id><pubmed_authors>Zuhra K</pubmed_authors><pubmed_authors>Tsukamoto T</pubmed_authors><pubmed_authors>Cerezo M</pubmed_authors><pubmed_authors>Lill R</pubmed_authors><pubmed_authors>Schulz V</pubmed_authors><pubmed_authors>Freibert SA</pubmed_authors><pubmed_authors>Boniecki MT</pubmed_authors><pubmed_authors>Maundrell K</pubmed_authors><pubmed_authors>Vartholomaiou E</pubmed_authors><pubmed_authors>Martinou JC</pubmed_authors><pubmed_authors>Hanschke S</pubmed_authors><pubmed_authors>Ferre SM</pubmed_authors><pubmed_authors>Cygler M</pubmed_authors><pubmed_authors>Szabo C</pubmed_authors><pubmed_authors>Rouaud F</pubmed_authors><pubmed_authors>Gonzalez-Ruiz V</pubmed_authors><pubmed_authors>Rudaz S</pubmed_authors><pubmed_authors>Serre-Beinier V</pubmed_authors><pubmed_authors>Montessuit S</pubmed_authors><pubmed_authors>Stehling O</pubmed_authors><pubmed_authors>Zangari J</pubmed_authors><pubmed_authors>Bhattacharya K</pubmed_authors></additional><is_claimable>false</is_claimable><name>D-cysteine impairs tumour growth by inhibiting cysteine desulfurase NFS1.</name><description>Selective targeting of cancer cells is a major challenge for cancer therapy. Many cancer cells overexpress the cystine/glutamate antiporter xCT/CD98, an L-cystine transport system that strengthens antioxidant defences, thereby promoting tumour survival and progression. Here, we show that the D-enantiomer of cysteine (D-Cys) is selectively imported into xCT/CD98-overexpressing cancer cell lines and impairs their proliferation, particularly under high oxygen concentrations. Intracellular D-Cys specifically inhibits the mitochondrial cysteine desulfurase NFS1, a key enzyme of cellular iron-sulfur protein biogenesis, by blocking sulfur mobilization due to steric constraints. NFS1 inhibition by D-Cys affects all cellular iron-sulfur cluster-dependent functions, including mitochondrial respirati</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-08T06:48:47.386Z</modification><creation>2026-04-07T23:31:07.794Z</creation></dates><accession>S-EPMC12373508</accession><cross_references><pubmed>40797101</pubmed><doi>10.1038/s42255-025-01339-1</doi></cross_references></HashMap>